552 related articles for article (PubMed ID: 33222290)
1. Perineal desquamation: An early sign of the Kawasaki disease phenotype of MIS-C.
Mazori DR; Derrick KM; Kapoor U; Haribhai M; Gist RE; Glick SA
Pediatr Dermatol; 2021 Jan; 38(1):253-256. PubMed ID: 33222290
[TBL] [Abstract][Full Text] [Related]
2. Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings.
Marzano AV; Cassano N; Moltrasio C; Verdoni L; Genovese G; Vena GA
Dermatology; 2022; 238(1):35-43. PubMed ID: 34062530
[TBL] [Abstract][Full Text] [Related]
3. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
Zhang QY; Xu BW; Du JB
World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
[TBL] [Abstract][Full Text] [Related]
4. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
Front Immunol; 2021; 12():632890. PubMed ID: 33732254
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing Multisystem Inflammatory Syndrome in Children From COVID-19, Kawasaki Disease and Toxic Shock Syndrome.
Godfred-Cato S; Abrams JY; Balachandran N; Jaggi P; Jones K; Rostad CA; Lu AT; Fan L; Jabbar A; Anderson EJ; Kao CM; Hunstad DA; Rosenberg RB; Zafferani MJ; Ede KC; Ballan W; Laham FR; Beltran Y; Bryant B; Meng L; Hammett TA; Oster ME; Bamrah Morris S; Belay ED
Pediatr Infect Dis J; 2022 Apr; 41(4):315-323. PubMed ID: 35093995
[TBL] [Abstract][Full Text] [Related]
6. Early Desquamating Perineal Erythema in a Febrile Infant: A Characteristic Clinical Feature of Kawasaki Disease.
Isidori C; Sebastiani L; Cardellini MC; Di Cara G; Rigante D; Esposito S
Int J Environ Res Public Health; 2017 Jun; 14(7):. PubMed ID: 28665334
[No Abstract] [Full Text] [Related]
7. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
[TBL] [Abstract][Full Text] [Related]
8. A case of multisystem inflammatory syndrome in children in a Japanese boy: with discussion of cytokine profile.
Fukuda S; Kaneta M; Miyake M; Ohya T; Miyakawa K; Iwamoto M; Ito S
Mod Rheumatol Case Rep; 2021 Jul; 5(2):442-447. PubMed ID: 33904379
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Laboratory Characteristics of Kawasaki Disease and COVID-19-Related Multisystem Inflammatory Syndrome in Children.
Phi DL; Dao TL; To MM; Nguyen TB; Nguyen DC; Gautret P; Hoang VT
J Korean Med Sci; 2023 Dec; 38(49):e410. PubMed ID: 38111281
[TBL] [Abstract][Full Text] [Related]
10. Multisystem inflammatory syndrome in children: Is there a linkage to Kawasaki disease?
Loke YH; Berul CI; Harahsheh AS
Trends Cardiovasc Med; 2020 Oct; 30(7):389-396. PubMed ID: 32702413
[TBL] [Abstract][Full Text] [Related]
11. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
Kabeerdoss J; Pilania RK; Karkhele R; Kumar TS; Danda D; Singh S
Rheumatol Int; 2021 Jan; 41(1):19-32. PubMed ID: 33219837
[TBL] [Abstract][Full Text] [Related]
12. Multisystem inflammatory syndrome (MIS-C) in Pakistani children: A description of the phenotypes and comparison with historical cohorts of children with Kawasaki disease and myocarditis.
Mohsin SS; Abbas Q; Chowdhary D; Khalid F; Sheikh AS; Ali Khan ZG; Aslam N; Bhatti OA; Inam M; Saleem AF; Bhutta AT
PLoS One; 2021; 16(6):e0253625. PubMed ID: 34153080
[TBL] [Abstract][Full Text] [Related]
13. Children with Kawasaki disease or Kawasaki-like syndrome (MIS-C/PIMS) at the time of COVID-19: are they all the same? Case series and literature review.
Marino A; Varisco T; Quattrocchi G; Amoroso A; Beltrami D; Venturiello S; Ripamonti A; Villa A; Andreotti M; Ciuffreda M; Cimaz R
Reumatismo; 2021 Apr; 73(1):48-53. PubMed ID: 33874647
[TBL] [Abstract][Full Text] [Related]
14. Multisystem inflammatory syndrome in children: A dysregulated autoimmune disorder following COVID-19.
Lee PI; Hsueh PR
J Microbiol Immunol Infect; 2023 Apr; 56(2):236-245. PubMed ID: 36720670
[TBL] [Abstract][Full Text] [Related]
15. Multisystemic Inflammatory Syndrome in Children and Kawasaki Disease: Parallels in Pathogenesis and Treatment.
Cannon L; Campbell MJ; Wu EY
Curr Allergy Asthma Rep; 2023 Jun; 23(6):341-350. PubMed ID: 37171672
[TBL] [Abstract][Full Text] [Related]
16. Characterizing the differences between multisystem inflammatory syndrome in children and Kawasaki disease.
Bar-Meir M; Guri A; Godfrey ME; Shack AR; Hashkes PJ; Goldzweig O; Megged O
Sci Rep; 2021 Jul; 11(1):13840. PubMed ID: 34226639
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2.
Yeo WS; Ng QX
Med Hypotheses; 2020 Nov; 144():110263. PubMed ID: 33254568
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 in children: Pathogenesis and current status.
Frenkel LD; Gomez F; Bellanti JA
Allergy Asthma Proc; 2021 Jan; 42(1):8-15. PubMed ID: 33404385
[No Abstract] [Full Text] [Related]
19. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.
Fabi M; Filice E; Biagi C; Andreozzi L; Palleri D; Mattesini BE; Rizzello A; Gabrielli L; Ghizzi C; Di Luca D; Caramelli F; De Fanti A; Lanari M
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696451
[TBL] [Abstract][Full Text] [Related]
20. A dermatologic perspective on multisystem inflammatory syndrome in children.
Naka F; Melnick L; Gorelik M; Morel KD
Clin Dermatol; 2021; 39(1):163-168. PubMed ID: 33972046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
